Listed

Propanc Biopharma, Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 14, 2021 and accepted by EDGAR at May 14, 2021, 17:25 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2021-01-01 to 2021-03-31$44.9kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2020-07-01 to 2021-03-31$145.9kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-01-01 to 2021-03-31−$428.0kus-gaap:OperatingIncomeLoss
Operating income9 months2020-07-01 to 2021-03-31−$1.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$102.9kus-gaap:InterestExpense
Interest expense9 months2020-07-01 to 2021-03-31$420.0kus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31−$112.3kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2020-07-01 to 2021-03-31−$112.3kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$417.7kus-gaap:NetIncomeLoss
Net income9 months2020-07-01 to 2021-03-31−$1.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31−$0.12us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2020-07-01 to 2021-03-31−$0.76us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2020-07-01 to 2021-03-31−$909.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2021-03-31$14.4kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$18.5kus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$28.0kus-gaap:Assets
Current liabilitiesAt period end2021-03-31$3.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$3.0mus-gaap:Liabilities
Long-term debtAt period end2021-03-31$950.2kus-gaap:LongTermDebt
Shareholders' equityAt period end2021-03-31−$3.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-21-011560. Last ingested by Listed: Nov 14, 2026, 18:42 ET. Listed shows no prices and gives no investment advice.